Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
INDIANAPOLIS , Nov. 1, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from the Phase 3 trial (EMBER-3) for imlunestrant, an oral selective estrogen receptor degrader
Three Buys and a Bail: Microsoft, Eli Lilly, Peloton, and Snap
02:33pm, Friday, 01'st Nov 2024
Gina Sanchez, Lido Advisors chief market strategist, joins CNBC's 'The Exchange' to discuss these stocks: Microsoft, Eli Lilly, Peloton, and Snap.
Here Are the Next 3 Stock Splits to Keep on Your Radar
08:11am, Friday, 01'st Nov 2024
A stock split divides existing shares into multiple new ones, increasing a given company's share count and making shares more affordable for those looking to buy in.
Market Movers: 2 Top Dividend Stocks I'm Watching No Matter Who Wins
07:30am, Friday, 01'st Nov 2024
With the upcoming election sparking volatility, I'm sharing two dividend stocks on my radar. These picks offer reliable growth potential, no matter the political outcome. Each stock has a solid track
Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip
05:44am, Friday, 01'st Nov 2024
The market overreacted to Lilly's Q3 earnings miss and full-year guidance cut.
Eli Lilly viewed positively despite Mounjaro, Zepbound disappointment - BoA
02:59pm, Thursday, 31'st Oct 2024
Bank of America has stuck by Eli Lilly and Co (NYSE:LLY) despite underwhelming sales of its weight loss and diabetes products Zepbound and Mounjaro in the third quarter. Reiterating a ‘buy' rating,
Eli Lilly Earnings Have Wall Street Jittery on Zepbound Sales. What Comes Next.
01:30pm, Thursday, 31'st Oct 2024
Sales of Zepbound and Mounjaro both missed Wall Street estimates by significant margin.
Wall Street sets Eli Lilly stock price for the next 12 months
11:11am, Thursday, 31'st Oct 2024
The ongoing earnings season has been filled with surprises in both directions. Some notable examples are Advanced Micro Devices (NASDAQ: AMD), which severely disappointed investors, and Garmin (NYSE:
MSFT, GOOGL "Overpenalized" & LLY, CMG "Overvalued"
10:55am, Thursday, 31'st Oct 2024
According to Dave Sekera with @morningstar, the markets are reacting too harshly to Meta Platforms (META) and Microsoft's (MSFT) earnings. He says both companies are "undervalued" when using Morningst
Buy, Sell, Or Hold LLY Stock At $850?
10:31am, Thursday, 31'st Oct 2024
Eli Lilly stock (NYSE: LLY) fell over 6% on Wednesday, October 30, after it posted downbeat results. The company reported revenue of $11.4 billion and adjusted earnings of $1.18 per share, well below
Are Eli Lilly's Lowered Expectations a Reason to Sell?
05:21am, Thursday, 31'st Oct 2024
Accounting for an acquisition Eli Lilly completed in August made a big impact on earnings expectations for 2024.
Eli Lilly and Company (LLY) Q3 2024 Earnings Call Transcript
03:34pm, Wednesday, 30'th Oct 2024
Eli Lilly and Company (NYSE:LLY ) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Joe Fletcher - Senior Vice President-Investor Relations Dave Ricks - Chief Executiv
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
03:00pm, Wednesday, 30'th Oct 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.1% on Wednesday.
What You May Have Missed From Eli Lilly's Q3 2024 Earnings Disappointment
02:47pm, Wednesday, 30'th Oct 2024
Eli Lilly's eyewatering upsurge this year was upended by its double-slashed full-year 2024 guidance following the Q3 earnings update this morning. The slight Q3 revenue miss continues to highlight vol
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
02:43pm, Wednesday, 30'th Oct 2024
Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as both medicines have largely recovered from widespread
